Denver, Colorado 80506


Purpose:

The purpose of this study is to develop and test an intervention to reduce bacterial and viral infections among injection drug users.


Study summary:

Injection drug use (IDU) is a major public health problem that is associated with a host of medical complications, including blood-borne viral disease (e.g., HIV, Hepatitis C) and bacterial infections (e.g., skin abscesses, endocarditis), that often result from high-risk drug injection practices. There are no current interventions designed to reduce bacterial infections among IDUs, despite high rates of infection. The objective of this study is to develop and test the efficacy of a skin and needle hygiene intervention for IDUs to reduce practices associated with bacterial and viral infections. In the first phase of the study, focus group interviews were conducted to determine key areas of emphasis for an intervention with this population. An initial intervention was developed, pilot tested, and refined. The final 2-session intervention combines psychoeducation, skill-building, and motivational interviewing. Following refinement of the intervention, a small randomized controlled trial (n = 60; 30 in each group) to examine the efficacy of the intervention compared to an assessment-only condition will be conducted. The goals of this two-year study are to: 1) reduce high-risk injection practices among active IDUs that lead to bacterial and viral infections, 2) improve skin and needle cleaning behavioral skills, and 3) increase skin cleaning prior to injection and reduce subcutaneous/intramuscular injection. In addition to examining these goals over a six-month period, the acceptability and feasibility of the intervention will be examined.


Criteria:

Inclusion Criteria: - 18 years of age or older - injection of heroin on at least three different days in the last week - injection of heroin for at least three months - visible track marks/puncture wounds from needles - positive urine screen for heroin Exclusion Criteria: - currently exhibiting active psychotic symptoms - cannot complete study assessments or the intervention - cannot provide informed consent - unable to provide names and contact information for at least two verifiable locator persons who will know where to find client - plans to relocate from area or be jail over next six months - have been in a Project Safe study in the last year - report being pregnant or attempting to become pregnant


NCT ID:

NCT01128920


Primary Contact:

Principal Investigator
Kristina T Phillips, Ph.D.
University of Northern Colorado

Kristina T Phillips, PhD
Phone: 970-351-2428
Email: kristina.phillips@unco.edu


Backup Contact:

Email: Jennifer.altman@ucdenver.edu
Jennifer Altman, M.A.
Phone: 303-315-0991


Location Contact:

Denver, Colorado 80506
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.